News & Articles

UTHealth Houston has enrolled the first patient in the Southeastern United States into a national Phase I/II clinical trial testing whether a neural cell therapy product can help inhibit the abnormal electrical activity that leads to an epileptic seizure.

UTHealth Houston and The Ocean Corporation are collaborating on UTHealth Houston’s Space Medicine Training Fellowship program, which now includes a two-week intensive training focused on hyperbaric technologies and analog environments akin to those astronauts experience during extravehicular activities (EVAs), or space walks.

Genetic variants linked to a rare form of bicuspid aortic valve disease that affects young adults and can lead to dangerous and potentially life-threatening aortic complications have been identified by researchers at UTHealth Houston.

A groundbreaking research project to understand how diet and eating patterns can affect the body’s internal clock and influence aging is underway at UTHealth Houston, thanks to a $3.3 million grant from the National Institute on Aging.

The Center for Clinical and Translational Sciences at UTHealth Houston has secured a $55.5 million grant from the National Center for Advancing Translational Sciences, an agency of the National Institutes of Health, extending its funding through 2031.

Bleeding is the most common cause of preventable death after injury. Researchers at UTHealth Houston are asking for community input on whether they should participate in a study that will compare two resuscitation treatments: whole blood versus traditional blood component therapy, and tranexamic acid versus no tranexamic acid. The goal is to compare which strategies can improve survival for children who have been seriously injured and are in danger of bleeding to death.

Men with dementia who were taking beta-blockers showed a slight decrease in the rate of bone loss compared with men who were not, according to a small observational study led by researchers at UTHealth Houston.

Groundbreaking research initiatives to advance the treatment of traumatic injuries at UTHealth Houston have been funded with $3.4 million in grants from the Trauma Research and Combat Casualty Collaborative (TRC4), an initiative of The University of Texas System.